Organoid-based 3D in vitro microphysiological systems as alternatives to animal experimentation for preclinical and clinical research

By sjmartinez • March 15, 2023

Mukhopadhyay C, Paul MK. Organoid-based 3D in vitro microphysiological systems as alternatives to animal experimentation for preclinical and clinical research. Arch Toxicol. 2023 Mar 14. doi: 10.1007/s00204-023-03466-8. Epub ahead of print. PMID: 36917352.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Epcoritamab plus rituximab, dexamethasone, cytarabine, oxaliplatin/carboplatin induces deep and durable responses in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma: results from the EPCORE NHL-2 trial

Abrisqueta P, Karimi YH, Morillo D, Cordoba R, Phillips T, De Vos S, Nijland M, Offner F, Andersson PO, Brody J, Cheah CY, Prieto PG,[...]

Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 results

Deng J, Pal A, Testa S, Xu JW, Tran LM, Graham DS, Hargil A, Subramanian A, Campbell KM, Limsuwannarot S, Chumpitaz Lavalle Á, Chin SC,[...]

Peak Oxygen Uptake Prediction From Resting and Submaximal Variables of Cardiopulmonary Exercise Testing

Lee Y, Feng J, Rahrooh A, Bui AAT, Cooper CB, Hsu JJ. Peak Oxygen Uptake Prediction From Resting and Submaximal Variables of Cardiopulmonary Exercise Testing.[...]